Showing 25–36 of 112 results

Gilotrif 40 mg Alternative – Afatin (Afatinib) 40 mg Tablet | Beacon Pharmaceuticals

Afatin 40 mg (Afatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Gilotrif. irreversible EGFR-family kinase inhibitor; used in selected EGFR-mutated non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Gleevec / Glivec 100 mg Alternative – Imacent (Imatinib) 100 mg Tablet | Incepta Pharmaceuticals

Imacent 100 mg (Imatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Gleevec / Glivec (Novartis).

Pack: 30 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Gleevec / Glivec 100 mg Alternative – Imaxen (Imatinib) 100 mg Tablet | Everest Pharmaceuticals

Imaxen 100 mg (Imatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Gleevec / Glivec (Novartis). It belongs to the BCR-ABL/KIT/PDGFR kinase inhibitor class and is used in selected chronic myeloid leukemia and gastrointestinal stromal tumor settings.

Active ingredient: Imatinib
Strength: 100 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Gleevec / Glivec 400 mg Alternative – Imacent (Imatinib) 400 mg Tablet | Incepta Pharmaceuticals

Imacent 400 mg (Imatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Gleevec / Glivec (Novartis).

Pack: 30 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Gleevec 100 mg Alternative – Imanix (Imatinib) 100 mg Tablet | Beacon Pharmaceuticals

Imanix 100 mg (Imatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Gleevec. BCR-ABL/KIT inhibitor; used in selected chronic myeloid leukemia and gastrointestinal stromal tumors. Prescription medicine. Brand comparison does not establish interchangeability.

Gleevec 400 mg Alternative – Imanix (Imatinib) 400 mg Tablet | Beacon Pharmaceuticals

Imanix 400 mg (Imatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Gleevec. BCR-ABL/KIT inhibitor; used in selected chronic myeloid leukemia and gastrointestinal stromal tumors. Prescription medicine. Brand comparison does not establish interchangeability.

Humira 40 mg Alternative – Advixa (Adalimumab) 40 mg Injection | Incepta Pharmaceuticals

Advixa 40 mg (Adalimumab) Injection is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Humira (AbbVie).

Pack: 1 prefilled syringe. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Hydrea 500 mg Alternative – Hydronix (Hydroxyurea) 500 mg Capsule | Beacon Pharmaceuticals

Hydronix 500 mg (Hydroxyurea) Capsule by Beacon Pharmaceuticals. Reference brand: Hydrea. antimetabolite; used in selected blood disorders including sickle cell disease and myeloproliferative conditions. Prescription medicine. Brand comparison does not establish interchangeability.

Ibrance 125 mg Alternative – Palbocent (Palbociclib) 125 mg Capsule | Incepta Pharmaceuticals

Palbocent 125 mg (Palbociclib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Ibrance (Pfizer).

Pack: 21 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Ibrance 125 mg Alternative – Palboxen (Palbociclib) 125 mg Capsule | Everest Pharmaceuticals

Palboxen 125 mg (Palbociclib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Ibrance (Pfizer). It belongs to the CDK4/6 inhibitor class and is used in selected HR-positive, HER2-negative breast cancer regimens.

Active ingredient: Palbociclib
Strength: 125 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Ibrance 125 mg Alternative – Palker (Palbociclib) 125 mg Capsule | Beacon Pharmaceuticals

Palker 125 mg (Palbociclib) Capsule by Beacon Pharmaceuticals. Reference brand: Ibrance. CDK4/6 inhibitor; used in selected HR-positive, HER2-negative breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Imbruvica 140 mg Alternative – Ibrucent (Ibrutinib) 140 mg Capsule | Incepta Pharmaceuticals

Ibrucent 140 mg (Ibrutinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Imbruvica (Pharmacyclics / Janssen).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.